Morgan Stanley analyst Erin Wright lowered the firm’s price target on Dentsply Sirona (XRAY) to $12 from $14 and keeps an Equal Weight rating on the shares.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Dentsply Sirona price target lowered to $13 from $16 at Mizuho
- Dentsply Sirona price target lowered to $12 from $14 at JPMorgan
- Dentsply Sirona price target lowered to $14 from $18 at Baird
- Dentsply Sirona price target lowered to $13 from $16 at Piper Sandler
- Dentsply Sirona Unveils Strategic Plan Amid Q3 Losses